10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
THERMO FISHER SCIENTIFIC INC. | ||
Ticker: TMO Fiscal Year: 2022 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 23, 2023) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 8,524 | 4,477 |
| Accounts receivable, less allowances of $189 and $150 | 8,115 | 7,977 |
| Inventories | 5,634 | 5,051 |
| Contract assets, net | 1,312 | 968 |
| Other current assets | 1,644 | 1,640 |
| Total current assets | 25,229 | 20,113 |
| Property, plant and equipment, net | 9,280 | 8,333 |
| Acquisition-related intangible assets, net | 17,442 | 20,113 |
| Other assets | 4,007 | 4,640 |
| Goodwill | 41,196 | 41,924 |
| Total assets | 97,154 | 95,123 |
| Liabilities, redeemable noncontrolling interest and equity | ||
| Current liabilities: | ||
| Short-term obligations and current maturities of long-term obligations | 5,579 | 2,537 |
| Accounts payable | 3,381 | 2,867 |
| Accrued payroll and employee benefits | 2,095 | 2,427 |
| Contract liabilities | 2,601 | 2,655 |
| Other accrued expenses | 3,354 | 2,950 |
| Total current liabilities | 17,010 | 13,436 |
| Deferred income taxes | 2,849 | 3,837 |
| Other long-term liabilities | 4,238 | 4,540 |
| Long-term obligations | 28,909 | 32,333 |
| Commitments and Contingencies | ||
| Redeemable noncontrolling interest | 116 | 122 |
| Equity: | ||
| Thermo Fisher Scientific Inc. shareholders equity: | ||
| Preferred stock, $100 par value, 50,000 shares authorized; none issued | ||
| Common stock, $1 par value, 1,200,000,000 shares authorized; 440,668,112 and 439,154,741 shares issued | 441 | 439 |
| Capital in excess of par value | 16,743 | 16,174 |
| Retained earnings | 41,910 | 35,431 |
| Treasury stock at cost, 50,157,275 and 44,720,112 shares | (12,017) | (8,922) |
| Accumulated other comprehensive items | (3,099) | (2,329) |
| Total Thermo Fisher Scientific Inc. shareholders equity | 43,978 | 40,793 |
| Noncontrolling interests | 54 | 62 |
| Total equity | 44,032 | 40,855 |
| Total liabilities, redeemable noncontrolling interest and equity | 97,154 | 95,123 |
| External Links | |
| THERMO FISHER SCIENTIFIC INC. (TMO) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |